Very Early Discharge After Coronary Artery Bypass Grafting Does Not Affect Readmission or Survival

Laura Seese,Ibrahim Sultan,Thomas Gleason,Yisi Wang,Forozan Navid,Floyd Thoma,Arman Kilic,Derek K. Afflu
DOI: https://doi.org/10.1016/j.athoracsur.2020.05.159
IF: 5.113
2021-03-01
The Annals of Thoracic Surgery
Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Background</h3><p>This study evaluated the impact of very early hospital discharge after coronary artery bypass grafting (CABG) on subsequent readmission and survival.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>Adults undergoing isolated CABG from 2011 to 2018 at a single institution were included. Patients were stratified on the basis of their postoperative length of hospital stay: short stay (≤4 days) and nonshort stay (&gt;4 days). The primary outcomes were longitudinal survival and freedom from hospital readmission. Secondary outcomes included rates of postoperative complications. Propensity score matching with a 1:1 ratio was performed to generate cohorts with comparable baseline characteristics.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>A total of 6327 patients underwent CABG during the study period, and a matched cohort of 2286 patients was identified. In matched analysis, the average Society of Thoracic Surgeons predicted risk of operative mortality was low in both groups (average, 0.7%). Rates of postoperative complications were low and several complication rates were even lower in the short-stay cohort: stroke (1.14% vs 0.26%; <em>P</em> = .01), renal failure (0.87% vs 0.09%; <em>P</em> = .007), reoperations (1.84% vs 0.26%; <em>P</em> &lt; .001), and new-onset atrial fibrillation (34.21% vs 13.04%; <em>P</em> &lt; .001). Survival was similar between the matched groups at 30 days (99.56% vs 99.21%), 1 year (97.73% vs 97.46%), and 5 years (91.15% vs 92.48%) (all <em>P</em> &gt; .05). Readmission rates were also comparable at all time intervals, and there were no differences in cardiac-related or heart failure–specific readmissions (all <em>P</em> &gt; .05). Risk-adjusted analyses confirmed these findings.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusions</h3><p>This study demonstrates that very early discharge within 4 days of isolated CABG is safe and has no substantial impact on subsequent mortality or readmission risk.</p>
surgery,cardiac & cardiovascular systems,respiratory system
What problem does this paper attempt to address?